Please use this identifier to cite or link to this item:
http://hdl.handle.net/10362/142863| Title: | Non-invasive orthopaedics leader turned medtech |
| Author: | Zeciri, Fitore |
| Advisor: | André, Rosário |
| Keywords: | Valuation Finance |
| Defense Date: | 14-Jan-2022 |
| Abstract: | The following paper represents an Equity Research report on Össur hf. The below section is the second part of a two-part series and focuses on the market analysis of the company. The aim of this part is to provide an in-depth overview of the non-invasive orthopedics market to facilitate the final valuation conducted in part two of the Equity Research. The market analysis includes a company and product overview, a competitive landscape as well as underlying company risk factors and other strategic considerations. |
| URI: | http://hdl.handle.net/10362/142863 |
| Designation: | A Work Project, presented as part of the requirements for the Award of a Masters Degree in Finance from the NOVA – School of Business and Economics |
| Appears in Collections: | NSBE: Nova SBE - MA Dissertations |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 28243_fitore_zeciri_part_1__ssur_211803_320934860.pdf | 1,07 MB | Adobe PDF | View/Open |
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.











